Press Releases

Results found (115)
August 15, 2007
A NEW CONSORTIUM IN THE WATER CLEANTECH FIELD INITIATED BY YISSUM AND THE...

The OCS authorized the three-year budget, with 15M NIS secured for the first year

August 12, 2007
YISSUM AND PROTALIX BIOTHERAPEUTICS SIGN AGREEMENT TO LICENSE...

Protalix BioTherapeutics to Explore Biodefense and Civilian Applications with Researchers from Hebrew University of Jerusalem

August 4, 2007
TEVA BUYS ASTHMA TREATMENT RIGHTS FROM YISSUM (HEBREW)

The treatment was found in testing to have eliminated four different types of allergic diseases in mice.

May 15, 2007
A NEW COOPERATION BETWEEN YISSUM AND PHARMATHENE INC. MAY LEAD TO THE...

PharmAthene's research is based on an an invention owned by Yissum

April 10, 2007
YISSUM SELLS ITS HOLDINGS IN BIOCANCELL THERAPUTICS TO CLAL BIOTECHNOLOGY...

CBI will purchase 24% of the cancer-drug developer; Yissum keeps its royalties agreement

December 25, 2006
YISSUM SUBSIDIARY SCT WINS 2M NIS GRANT FOR JUVENILE DIABETES RESEARCH...

This grant was received from the World Fund for Juvenile Diabetes Research and D-Cure.

October 30, 2006
KAZAKHSTAN MINISTER OF SCIENCE & EDUCATION VISITS YISSUM (HEBREW ARTICLE)

Yissum will aid Kazakhstan in establishing technology transfer facilities as part of the Kazakhstan National Center for Biotechnology.